Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Gui · SciRah

Researcher profile · Semantic Scholar

G. Gui

Share profile

G. Gui — researcher profile on SciRah

h-index: 14
Works: 51
Citations: 1,405

Most-cited papers

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.
C. Hourigan, L. Dillon, G. Gui, Brent Logan +18 more
2019Journal of Clinical Oncology381 citations Open access
Semantic Scholar
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry
K. Oetjen, K. Lindblad, M. Goswami, G. Gui +5 more
2018bioRxiv232 citations Open access
Semantic Scholar
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial
B. Scott, M. Pasquini, M. Fei, Raphael Fraser +19 more
2021Transplantation and Cellular Therapy138 citations Open access
Semantic Scholar
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
L. Dillon, G. Gui, K. Page, N. Ravindra +17 more
2023Journal of the American Medical Association (JAMA)134 citations Open access
Semantic Scholar
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
M. Goswami, G. Gui, Laura W. Dillon, K. Lindblad +18 more
2021Journal for ImmunoTherapy of Cancer80 citations Open access
Semantic Scholar
Heterogeneity in refractory acute myeloid leukemia
S. Horibata, G. Gui, J. Lack, C. DeStefano +2 more
2019Proceedings of the National Academy of Sciences of the United States of America62 citations Open access
Semantic Scholar
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia.
L. Dillon, G. Gui, N. Ravindra, G. Andrew +21 more
2024JAMA Oncology58 citations Open access
Semantic Scholar
Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.
Haydar Çelik, K. Lindblad, B. Popescu, G. Gui +16 more
2020Blood Advances49 citations Open access
Semantic Scholar
Personalized Single-Cell Proteogenomics to Distinguish Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis
Laura W. Dillon, Jack Y. Ghannam, C. Nosiri, G. Gui +23 more
2020medRxiv36 citations Open access
Semantic Scholar
Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells
Qian Li, Yi Feng, Yingchao Xue, Xi-Ping Zhan +9 more
2021Molecular Neurodegeneration29 citations Open access
Semantic Scholar
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome
L. Dillon, G. Gui, Brent Logan, M. Fei +18 more
2020medRxiv25 citations Open access
Semantic Scholar
Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML
G. Gui, Molly A Bingham, Julius Herzog, A. Wong-Rolle +14 more
2025Science Advances19 citations Open access
Semantic Scholar
Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance
Nicholas H. McCarthy, G. Gui, F. Dumézy, C. Roumier +9 more
2024Leukemia18 citations Open access
Semantic Scholar
Frondoside A Inhibits a MYC-driven Medulloblastoma Model Derived from Human Induced Pluripotent Stem Cells
Yingchao Xue, Yi Fu, Feng-Hong Zhao, G. Gui +7 more
2021Molecular Cancer Therapeutics16 citations Open access
Semantic Scholar
EGFR Activates a TAZ-driven Oncogenic Program in Glioblastoma
Minling Gao, Yi Fu, Wei-Qiang Zhou, G. Gui +7 more
2021Cancer Research14 citations Open access
Semantic Scholar
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
G. Gui, N. Ravindra, Pranay S. Hegde, G. Andrew +19 more
2024Bone Marrow Transplantation13 citations Open access
Semantic Scholar
Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.
C. Hourigan, L. Dillon, G. Gui, N. Ravindra +16 more
2022Journal of Clinical Oncology11 citations
Semantic Scholar
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
G. Gui, N. Ravindra, Pranay S. Hegde, G. Andrew +19 more
2024Bone Marrow Transplantation10 citations Open access
Semantic Scholar
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide
N. Ravindra, L. Dillon, G. Gui, Matthew Smith +5 more
2024Bone Marrow Transplantation9 citations Open access
Semantic Scholar
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
K. Lindblad, Julie Thompson, G. Gui, Janet Valdez +10 more
2018Blood9 citations Open access
Semantic Scholar
MRD Assessment as a Surrogate Marker in New Drug Development in AML
G. Gui, C. Hourigan
2022Cancer Journal8 citations Open access
Semantic Scholar
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
Pranay S. Hegde, G. Andrew, G. Gui, N. Ravindra +16 more
2024Bone Marrow Transplantation7 citations Open access
Semantic Scholar
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia
A. Pyzer, L. Dillon, E. Sharon, Theodore G. Karrison +29 more
2025Blood Advances6 citations Open access
Semantic Scholar
Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AML
G. Gui, Molly A. Bingham, Julius Herzog, A. Wong-Rolle +14 more
2025bioRxiv5 citations Open access
Semantic Scholar
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia
C. Hourigan, Lisanne Beugelink, Jad Othman, G. Gui +17 more
2026Blood4 citations Open access
Semantic Scholar
C9orf72 Hexanucleotide Repeat RNA Drives Transcriptional Dysregulation Through Genome-wide DNA:RNA Hybrid G-quadruplexes
Honghe Liu, Mingming Liu, Yang Liu, G. Gui +12 more
2026Neuron4 citations Open access
Semantic Scholar
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide
N. Ravindra, L. Dillon, G. Gui, Matthew L. Smith +5 more
2023medRxiv4 citations Open access
Semantic Scholar
Significant Inter-Laboratory Variability in Measurable Residual Disease Multiparameter Flow Cytometry Testing Prior to Allogeneic Transplantation Impedes Outcome Prediction: A CIBMTR Analysis
J. Tettero, G. Gui, Filippo Milano, Nelli Benjanyan +4 more
2025Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia
R. Al-Ali, G. Gui, N. Ravindra, G. Andrew +24 more
2025Bone Marrow Transplantation3 citations Open access
Semantic Scholar
DNA Sequencing in Adults With Acute Myeloid Leukemia to Detect Residual Disease Prior to Hematopoietic Cell Transplant-Reply.
G. Gui, L. Dillon, C. Hourigan
2023Journal of the American Medical Association (JAMA)3 citations
Semantic Scholar
Measurable Residual IDH1 before Allogeneic Transplant for Acute Myeloid Leukemia
G. Gui, L. Dillon, N. Ravindra, Pranay S. Hegde +18 more
2023medRxiv3 citations Open access
Semantic Scholar
Measurable Residual IDH2 before Allogeneic Transplant for Acute Myeloid Leukemia
G. Gui, L. Dillon, N. Ravindra, Pranay S. Hegde +19 more
2023Blood3 citations
Semantic Scholar
Measurable Residual Mutated NPM1 before Allogeneic Transplant for Acute Myeloid Leukemia
R. Al-Ali, G. Gui, N. Ravindra, G. Andrew +24 more
2024Blood2 citations Open access
Semantic Scholar
Persistence of FLT3-TKD in Blood Prior to Allogeneic Transplant Is Associated with Increased Relapse and Death in Adults with AML in First Remission
Pranay S. Hegde, G. Andrew, G. Gui, N. Ravindra +16 more
2023Blood2 citations Open access
Semantic Scholar
Pre- and Post-Transplant Measurable Residual IDH Mutations Are Not Associated with Relapse in Patients with IDH-Mutated AML
N. Ravindra, L. Dillon, G. Gui, C. Hourigan +1 more
2022Blood2 citations Open access
Semantic Scholar
Measurable Residual Disease Before Reduced-Intensity Allogeneic Transplantation in Patients With Myeloid Malignancy.
G. Gui, Laura W. Dillon, C. Hourigan
2021Journal of Clinical Oncology2 citations
Semantic Scholar
Genomics of Acute Myeloid Leukemia at Diagnosis and Remission
K. Yu, L. Dillon, J. Tettero, G. Gui +41 more
2025medRxiv1 citations
Semantic Scholar
The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission
Kai Yu, L. Dillon, J. Tettero, G. Gui +60 more
2025Blood1 citations
Semantic Scholar
Overall survival, conditioning, and MRD in MORPHO
G. Gui, C. Hourigan
2025Blood Advances1 citations
Semantic Scholar
Measurable Residual FLT3-ITD before Allogeneic Transplant for Acute Myeloid Leukemia
L. Dillon, G. Gui, N. Ravindra, G. Andrew +17 more
2023Blood1 citations Open access
Semantic Scholar
Spatial-Temporal Multiomic Analysis of Tumor-Immune Interactions in Patients with AML Receiving Pembrolizumab and Decitabine
G. Gui, A. Wong-Rolle, L. Dillon, M. Goswami +7 more
2022Blood1 citations Open access
Semantic Scholar
Pre-MEASURE: FLT3-ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission
L. Dillon, G. Gui, N. Ravindra, Z. Wong +17 more
2022medRxiv1 citations Open access
Semantic Scholar
A Novel Proteomic Profiling of the Bone Marrow Microenvironment Reveals Elevated Levels of the Chemokine CCL23 Isoforms in Acute Myeloid Leukemia
Haydar Çelik, K. Lindblad, B. Popescu, G. Fantoni +16 more
2019Blood1 citations Open access
Semantic Scholar
Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysis.
J. Tettero, Mei-Jie Zhang, Wen-Tong Liu, M. Nawas +11 more
2026Haematologica0 citations Open access
Semantic Scholar
Quantify Heterogeneity in Treatment Effects; A Case Study for Patients with Acute Myeloid Leukemia (AML)
G. Gui, L. Dillon, S. Zeger, C. Hourigan
2025Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
Fnih MRD in AML Biomarkers Consortium: Evaluation of Methods for Detection of FLT3 internal Tandem Duplication Measurable Residual Disease in Acute Myeloid Leukemia
L. Dillon, L. Beppu, G. Gui, R. Al-Ali +18 more
2025Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
SurvivorCHIP: Evaluation of clonal hematopoiesis in women treated for breast cancer.
Reem Bahr, C. Nosiri, G. Gui, D. Mukherjee +10 more
2024Journal of Clinical Oncology0 citations
Semantic Scholar
Single-Cell Transcriptomic and Proteomic Analysis of Acute Myeloid Leukemia (AML) Patients with Abnormalities on Chromosome 7
G. Gui, M. Goswami, C. Nosiri, L. Dillon +5 more
2021Blood0 citations Open access
Semantic Scholar
Highly Multiplexed Cell Surface Immunophenotyping with Genotyping and Concurrent Transcriptomic Analysis of NPM1 mutated Acute Myeloid Leukemia
D. Mukherjee, G. Gui, L. Dillon, C. Hourigan
2021Blood0 citations
Semantic Scholar
Abstract 3756: Highly multiplexed proteomic assessment of the human acute myeloid leukemia bone marrow microenvironment
B. Popescu, K. Lindblad, G. Fantoni, G. Gui +10 more
2019Tumor Biology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Dillon×34
Invite
L. Dillon — researcher profile on SciRah
C. Hourigan×31
Invite
C. Hourigan — researcher profile on SciRah
N. Ravindra×16
Invite
N. Ravindra — researcher profile on SciRah
G. Andrew×15
Invite
G. Andrew — researcher profile on SciRah

×15

Invite

F. El Chaer — researcher profile on SciRah

C. Hourigan×14

Invite

C. Hourigan — researcher profile on SciRah

Invite

Z. Wong — researcher profile on SciRah

M. D. De Lima×13

Invite

M. D. De Lima — researcher profile on SciRah

P. Kebriaei×13

Invite

P. Kebriaei — researcher profile on SciRah

Invite

W. Saber — researcher profile on SciRah

Invite

M. Litzow — researcher profile on SciRah

Invite

K. Page — researcher profile on SciRah